REGENERX BIOPHARMACEUTICALS INC Quarterly Common Stock, Shares, Issued from Q4 2010 to Q1 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Regenerx Biopharmaceuticals Inc quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q1 2023.
  • Regenerx Biopharmaceuticals Inc Common Stock, Shares, Issued for the quarter ending March 31, 2023 was 144M shares, unchanged year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 144M 0 0% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 144M 0 0% Dec 31, 2022 10-Q 2023-05-15
Q3 2022 144M 0 0% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 144M +103K +0.07% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 144M +10M +7.49% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 144M +10.1M +7.58% Dec 31, 2021 10-K 2023-04-11
Q3 2021 144M +10.1M +7.58% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 143M +10M +7.5% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 134M +105K +0.08% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 133M +1.94M +1.47% Dec 31, 2020 10-K 2022-03-30
Q3 2020 133M +1.94M +1.47% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 133M +1.94M +1.47% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 133M +2.94M +2.25% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 132M +3.07M +2.39% Dec 31, 2019 10-K 2021-03-02
Q3 2019 132M +3.07M +2.39% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 132M +11.9M +9.92% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 131M +10.9M +9.09% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 128M +18.6M +17% Dec 31, 2018 10-K 2020-03-20
Q3 2018 128M +21.5M +20.2% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 120M +12.8M +11.9% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 120M +12.9M +12% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 110M +3M +2.81% Dec 31, 2017 10-K 2019-03-29
Q3 2017 107M +95.6K +0.09% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 107M +95.6K +0.09% Jun 30, 2017 10-Q 2017-08-21
Q1 2017 107M +5.15M +5.06% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 107M +5.15M +5.06% Dec 31, 2016 10-K 2018-03-29
Q3 2016 107M +5.15M +5.06% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 107M +5.15M +5.06% Jun 30, 2016 10-Q 2016-08-22
Q1 2016 102M +324K +0.32% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 102M +324K +0.32% Dec 31, 2015 10-K 2017-03-29
Q3 2015 102M +324K +0.32% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 102M +8.66M +9.31% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 101M +8.33M +8.96% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 101M +19.6M +24% Dec 31, 2014 10-K 2016-04-11
Q3 2014 101M +19.6M +24% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 93M +11.3M +13.8% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 93M +11.3M +13.8% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 81.7M 0 0% Dec 31, 2013 10-K 2015-03-31
Q3 2013 81.7M 0 0% Sep 30, 2013 10-Q 2013-11-18
Q2 2013 81.7M +54.2K +0.07% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 81.7M +343K +0.42% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 81.7M +343K +0.42% Dec 31, 2012 10-K 2014-04-04
Q3 2012 81.7M +1.16M +1.44% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 81.7M +1.72M +2.15% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 81.4M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 81.4M +7.86M +10.7% Dec 31, 2011 10-K 2013-04-16
Q3 2011 80.6M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 80M Jun 30, 2011 10-Q 2011-08-05
Q4 2010 73.5M Dec 31, 2010 10-K 2012-04-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.